Dcf Advisers, LLC Ionis Pharmaceuticals Inc Transaction History
Dcf Advisers, LLC
- $195 Million
- Q1 2025
A detailed history of Dcf Advisers, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Dcf Advisers, LLC holds 95,000 shares of IONS stock, worth $4.12 Million. This represents 1.47% of its overall portfolio holdings.
Number of Shares
95,000
Previous 82,882
14.62%
Holding current value
$4.12 Million
Previous $2.9 Million
1.07%
% of portfolio
1.47%
Previous 1.63%
Shares
4 transactions
Others Institutions Holding IONS
# of Institutions
396Shares Held
145MCall Options Held
916KPut Options Held
541K-
Vanguard Group Inc Valley Forge, PA16.4MShares$711 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$702 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$536 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$448 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$365 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $6.16B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...